Pharmaceutics International, Inc. (Pii), has expanded its commercial team with the additions of Wayne Ideus, Wayne Grellner and Ryan McFarlane. 
 
Wayne Ideus will serve as director, business development. He joins the company with more than 30 years of pharmaceutical industry experience, across scientific, product development and business development roles, with organizations such as Marion Laboratories, DPT, Aptuit and most recently Mallinckrodt Pharmaceuticals. Mr. Grellner has held account management roles with Catalent, Ben Venue Labs and DSM/Patheon, and prior to Pii, business development with Samsung BioLogics. 
 
Ryan McFarlane was appointed executive director, business management. He joins the company from Acurian (a PPD company) following a nearly 20-year tenure at Patheon, where he gained broad experience across manufacturing, project management, commercial operations, business & supply chain management, and operational excellence. While Wayne Ideus and Wayne Grellner will add depth to Pii’s market engagement, Ryan McFarlane will collaborate cross-functionally to ensure the company delivers on its commitments, and effectively applies Pharmaceutics Know-How™ across the product development & supply continuum.  
 
“The appointment of these seasoned business executives to Pii’s commercial team reflects our commitment to growth, our dedication to the customer experience, and further enhances our ability to respond to an increasing market demand for CDMO services. Pii’s leadership team is pleased to welcome these gentlemen to the organization, and is looking forward to their contributions to our strategic objectives,” said Hank Nowak, Pii’s vice president of business development.